Following approval by the Chinese State Drug Administration, Pharmagenesis has begun selling a liver-specific MRI agent in China. The agent, Feridex, was developed by Advanced Magnetics. About 240 million people in China are carriers of the hepatitis B
Following approval by the Chinese State Drug Administration, Pharmagenesis has begun selling a liver-specific MRI agent in China. The agent, Feridex, was developed by Advanced Magnetics. About 240 million people in China are carriers of the hepatitis B virus, a leading cause of hepatoma, which is one of the 10 most frequently occurring cancers in China.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.